Versant Capital Management Inc Boosts Position in Humana Inc. (NYSE:HUM)

Versant Capital Management Inc grew its holdings in shares of Humana Inc. (NYSE:HUM) by 15.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 387 shares of the insurance provider’s stock after buying an additional 52 shares during the quarter. Versant Capital Management Inc’s holdings in Humana were worth $98,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the business. Moors & Cabot Inc. increased its holdings in Humana by 2.5% in the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock valued at $519,000 after purchasing an additional 40 shares in the last quarter. OLD National Bancorp IN lifted its position in Humana by 1.8% during the 3rd quarter. OLD National Bancorp IN now owns 2,613 shares of the insurance provider’s stock worth $828,000 after acquiring an additional 45 shares in the last quarter. Your Advocates Ltd. LLP boosted its holdings in Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after acquiring an additional 45 shares during the period. Brooklyn Investment Group boosted its holdings in Humana by 6.7% in the 3rd quarter. Brooklyn Investment Group now owns 736 shares of the insurance provider’s stock worth $233,000 after acquiring an additional 46 shares during the period. Finally, Demars Financial Group LLC grew its position in Humana by 2.7% in the third quarter. Demars Financial Group LLC now owns 1,950 shares of the insurance provider’s stock valued at $618,000 after acquiring an additional 52 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of recent research reports. Jefferies Financial Group downgraded shares of Humana from a “buy” rating to a “hold” rating and decreased their target price for the company from $519.00 to $253.00 in a research note on Monday, October 7th. Truist Financial lowered their target price on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a research note on Friday, October 11th. UBS Group cut their price target on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. Leerink Partnrs lowered Humana from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, Piper Sandler lowered Humana from an “overweight” rating to a “neutral” rating and cut their target price for the company from $392.00 to $274.00 in a research report on Thursday, October 3rd. Twenty equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $300.50.

Humana Stock Up 3.9 %

HUM stock opened at $262.47 on Friday. The firm’s 50-day moving average is $272.60 and its two-hundred day moving average is $313.96. The company has a market capitalization of $31.60 billion, a price-to-earnings ratio of 23.25, a price-to-earnings-growth ratio of 2.12 and a beta of 0.55. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $471.37. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, analysts forecast that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.35%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Insider Activity

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.32% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.